Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Landscape Professional Research Report 2025

Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Landscape Professional Research Report 2025

Research Summary

The Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a preventive measure used in the swine industry to control and manage infections caused by the PRRS virus. PRRS is a viral disease that affects pigs, causing reproductive problems in sows and respiratory issues in pigs of all ages. The vaccine is designed to stimulate an immune response in pigs, helping them develop immunity against the PRRS virus. There are different types of PRRS vaccines, including modified live vaccines and killed vaccines. Modified live vaccines contain weakened forms of the virus, while killed vaccines contain inactivated virus particles. The choice of vaccine type depends on factors such as the specific strain of the virus, the age of the pigs, and the production system. PRRS vaccination is a crucial component of swine health management strategies to reduce the impact of the disease on reproductive performance and overall herd health.

According to DIResearch's in-depth investigation and research, the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Merck, HIPRA, Sinopharm Animal Health, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim, Harbin Pharmaceutical Group etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Include:

Merck

HIPRA

Sinopharm Animal Health

Ceva Santé Animale

CAVAC

Bioveta

Jinyu Bio-Technology

Zoetis

Boehringer Ingelheim

Harbin Pharmaceutical Group

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Segment Include:

Live Vaccine

Inactivated Vaccine

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Application Include:

Large White Pigs

Duroc Pigs

Landrace Pigs

Hampshire Pigs

Pietrain Pigs

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry PESTEL Analysis

Chapter 3: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources